These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31105842)

  • 1. Quantitative assessment of human uterine fibroid xenograft using sequential in vivo bioluminescence imaging.
    Pan Y; Xiao T; Zhou Y; Chai Z; Xu Z; Dai M; Chen X; Suo G; Tao D
    Am J Transl Res; 2019; 11(4):2359-2369. PubMed ID: 31105842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous administration of D-luciferin is an effective alternative to intraperitoneal injection in bioluminescence imaging of xenograft tumors in nude mice.
    Khalil AA; Jameson MJ; Broaddus WC; Chung TD; Golding SE; Dever SM; Rosenberg E; Valerie K
    ISRN Mol Imaging; 2013; 2013():. PubMed ID: 25392739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of subcutaneous and intraperitoneal injection of D-luciferin for in vivo bioluminescence imaging.
    Inoue Y; Kiryu S; Izawa K; Watanabe M; Tojo A; Ohtomo K
    Eur J Nucl Med Mol Imaging; 2009 May; 36(5):771-9. PubMed ID: 19096841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Influence of Hypoxia and pH on Bioluminescence Imaging of Luciferase-Transfected Tumor Cells and Xenografts.
    Khalil AA; Jameson MJ; Broaddus WC; Lin PS; Dever SM; Golding SE; Rosenberg E; Valerie K; Chung TD
    Int J Mol Imaging; 2013; 2013():287697. PubMed ID: 23936647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine xenograft model for human uterine fibroids: an in vivo imaging approach.
    Suo G; Sadarangani A; Lamarca B; Cowan B; Wang JY
    Reprod Sci; 2009 Sep; 16(9):827-42. PubMed ID: 19516078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic modeling and analysis of dynamic bioluminescence imaging of substrates administered by intraperitoneal injection.
    Dai Y; Chen D; Wang G; Yin J; Zhan Y; Wu K; Liang J; Chen X
    Quant Imaging Med Surg; 2020 Feb; 10(2):389-396. PubMed ID: 32190565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic bioluminescence imaging for quantitative tumour burden assessment using IV or IP administration of D: -luciferin: effect on intensity, time kinetics and repeatability of photon emission.
    Keyaerts M; Verschueren J; Bos TJ; Tchouate-Gainkam LO; Peleman C; Breckpot K; Vanhove C; Caveliers V; Bossuyt A; Lahoutte T
    Eur J Nucl Med Mol Imaging; 2008 May; 35(5):999-1007. PubMed ID: 18180921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing live-animal bioluminescence imaging prediction of tumor burden in human prostate cancer xenograft models in SCID-NSG mice.
    Kim S; Zhang Y; Tang S; Qin C; Karelia D; Sharma A; Jiang C; Lu J
    Prostate; 2019 Jun; 79(9):949-960. PubMed ID: 30958914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of imaging after d-luciferin injection affects the longitudinal assessment of tumor growth using in vivo bioluminescence imaging.
    Inoue Y; Kiryu S; Watanabe M; Tojo A; Ohtomo K
    Int J Biomed Imaging; 2010; 2010():471408. PubMed ID: 20671955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive visualization of tumor growth in a human colorectal liver metastases xenograft model using bioluminescence in vivo imaging.
    Thalheimer A; Korb D; Bönicke L; Wiegering A; Mühling B; Schneider M; Koch S; Riedel SS; Germer CT; Beilhack A; Brändlein S; Otto C
    J Surg Res; 2013 Nov; 185(1):143-51. PubMed ID: 23998649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous Administration-Oriented Pharmacokinetic Model for Dynamic Bioluminescence Imaging.
    Dai Y; Wang G; Chen D; Yin J; Zhan Y; Nie Y; Wu K; Liang J; Chen X
    IEEE Trans Biomed Eng; 2019 Mar; 66(3):843-847. PubMed ID: 30047868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of disease progression by bioluminescence imaging and magnetic resonance imaging in an animal model of hematologic malignancy.
    Inoue Y; Izawa K; Tojo A; Nomura Y; Sekine R; Oyaizu N; Ohtomo K
    Exp Hematol; 2007 Mar; 35(3):407-15. PubMed ID: 17309821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect.
    Szentirmai O; Baker CH; Lin N; Szucs S; Takahashi M; Kiryu S; Kung AL; Mulligan RC; Carter BS
    Neurosurgery; 2006 Feb; 58(2):365-72; discussion 365-72. PubMed ID: 16462491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Drug Excipient Cyclodextrin Interacts With d-Luciferin and Interferes With Bioluminescence Imaging.
    Kumar JS; Miller Jenkins LM; Gottesman MM; Hall MD
    Mol Imaging; 2016; 15():. PubMed ID: 27030398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic Resonance Signal Intensity Ratio Measurement Before Uterine Artery Embolization: Ability to Predict Fibroid Size Reduction.
    Duvnjak S; Ravn P; Green A; Andersen PE
    Cardiovasc Intervent Radiol; 2017 Dec; 40(12):1839-1844. PubMed ID: 28597064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing the dosimetry for high-intensity focused ultrasound ablation of uterine fibroids: a retrospective study.
    Peng S; Zhang L; Hu L; Chen J; Ju J; Wang X; Zhang R; Wang Z; Chen W
    Medicine (Baltimore); 2015 Apr; 94(13):e650. PubMed ID: 25837756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of MR-guided focused ultrasound treatment and laparoscopic myomectomy for symptomatic uterine fibroid tumors.
    Mohr-Sasson A; Machtinger R; Mashiach R; Nir O; Inbar Y; Maliyanker N; Goldenberg M; Rabinovici J
    Am J Obstet Gynecol; 2018 Oct; 219(4):375.e1-375.e7. PubMed ID: 30217580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABCG2/BCRP expression modulates D-Luciferin based bioluminescence imaging.
    Zhang Y; Bressler JP; Neal J; Lal B; Bhang HE; Laterra J; Pomper MG
    Cancer Res; 2007 Oct; 67(19):9389-97. PubMed ID: 17909048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression and regulation of NR2F2 and CTNNB1 in uterine fibroids.
    Zaitseva M; Holdsworth-Carson SJ; Waldrip L; Nevzorova J; Martelotto L; Vollenhoven BJ; Rogers PA
    Reproduction; 2013 Aug; 146(2):91-102. PubMed ID: 23704310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo bioluminescence imaging using orthotopic xenografts towards patient's derived-xenograft Medulloblastoma models.
    Asadzadeh F; Ferrucci V; DE Antonellis P; Zollo M
    Q J Nucl Med Mol Imaging; 2017 Mar; 61(1):95-101. PubMed ID: 27982543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.